The Kable

The Kable

💊 J&J halts Covid-19 vaccine production, Pfizer predicts another bumper year, Deloitte expands, BioSplice contracts, #HKhamsters report from the ether

Vinod's avatar
Vinod
Feb 09, 2022
∙ Paid

Thank god it’s Wednesday. Which means only two more days to the weekend. And thinking about vaccine inequity. Which is covered in today’s issue. Along with news from the anti-aging space. And approvals and investments in and from India. And Deloitte applying healthcare learning to consumer services.

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2026 The Kable · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture